. Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men. Am J Physiol Endocrinol Metab 290: E1198 -E1204, 2006. First published January 3, 2006 doi:10.1152/ajpendo.00407.2005.-The plasma glucose excursion may influence the metabolic responses after oral glucose ingestion. Although previous studies adressed the effects of hyperglycemia in conditions of hyperinsulinemia, it has not been evaluated whether the route of glucose administration (oral vs. intravenous) plays a role. Our aim was to determine the effects of moderately controlled hyperglycemia on glucose metabolism before and after oral glucose ingestion. Eight normal men underwent two oral glucose clamps at 6 and 10 mmol/l plasma glucose. Glucose turnover and cycling rates were measured by infusion of [ 2 H7]glucose. The oral glucose load was labeled by D-[6,6-2 H2]glucose to monitor exogenous glucose appearance, and respiratory exchanges were measured by indirect calorimetry. Sixty percent of the oral glucose load appeared in the systemic circulation during both the 6 and 10 mmol/l plasma glucose tests, although less endogenous glucose appeared during the 10 mmol/l tests before glucose ingestion (P Ͻ 0.05). This inhibitory effect of hyperglycemia was not detectable after oral glucose ingestion, although glucose utilization was increased (ϩ28%, P Ͻ 0.05) due to increased nonoxidative glucose disposal [10 vs. 6 mmol/l: ϩ20%, not significant (NS) before oral glucose ingestion; ϩ40%, P Ͻ 0.05 after oral glucose ingestion]. Glucose cycling rates were increased by hyperglycemia (ϩ13% before oral glucose ingestion, P Ͻ 0.001; ϩ31% after oral glucose ingestion, P Ͻ 0.05) and oral glucose ingestion during both the 6 (ϩ10%, P Ͻ 0.05) and 10 mmol/l (ϩ26%, P Ͻ 0.005) tests. A moderate hyperglycemia inhibits endogenous glucose production and contributes to glucose tolerance by enhancing nonoxidative glucose disposal. Hyperglycemia and oral glucose ingestion both stimulate glucose cycling. glucose tolerance; endogenous glucose production; glucose cycle; glucose disposal rate IN NORMAL INDIVIDUALS, oral glucose ingestion is followed by a number of metabolic events that condition glucose tolerance. The major portion of ingested glucose appears in the peripheral circulation, although some is retained in the splanchnic bed, and endogenous glucose production is slightly reduced (25, 35) . Ten to fifteen percent of the ingested glucose is cycled in the liver participating in the total glucose output after a firstpass splanchnic uptake (6). There is an increase in both oxidative (energy production) and nonoxidative (energy storage essentially as glycogen in muscles and liver, but also possibly as lipids) glucose disposal (15, 25, 35) .
IN NORMAL INDIVIDUALS, oral glucose ingestion is followed by a number of metabolic events that condition glucose tolerance. The major portion of ingested glucose appears in the peripheral circulation, although some is retained in the splanchnic bed, and endogenous glucose production is slightly reduced (25, 35) . Ten to fifteen percent of the ingested glucose is cycled in the liver participating in the total glucose output after a firstpass splanchnic uptake (6) . There is an increase in both oxidative (energy production) and nonoxidative (energy storage essentially as glycogen in muscles and liver, but also possibly as lipids) glucose disposal (15, 25, 35) .
Hormonal responses play an important role in these changes. Euglycemic clamp studies have shown that insulin stimulates glucose utilization (8) and inhibits endogenous glucose production (22) . Low plasma glucagon levels also play a role in the reduction of endogenous glucose production (6, 25) .
The glycemic response after glucose ingestion may also contribute to these changes. Hyperglycemic clamp studies have shown that hyperglycemia can specifically reduce endogenous glucose production (7, 23) and stimulate oxidative and nonoxidative glucose disposal (21, 28) . However, the fate of glucose may differ according to the route of glucose administration (i.e., oral vs. intravenous). Therefore, we used an oral glucose-clamp technique (OG-clamp) (27) , which specifically enables the study of the route of glucose administration at constant glycemia.
We measured endogenous glucose production and oxidative and nonoxidative glucose disposal in eight normal middle-aged men before and after ingestion of a 0.7 g/kg glucose load. The oral load was labeled by dideuterated glucose to measure the rate of exogenous oral glucose appearance. Glucose turnover and cycling rates were measured by the infusion of [ 2 H 7 ] glucose (41) . Plasma glucose, insulin, and glucagon levels were controlled by the pancreatic clamp technique (infusion of somatostatin plus replacement dose of glucagon plus insulin infusion). To determine the effect of a moderate hyperglycemia, all of the subjects were studied twice at plasma glucose levels of 6 and 10 mmol/l.
MATERIALS AND METHODS
Subjects. Eight subjects were studied and underwent the two tests in a random order. Subjects were healthy, middle-aged men (age: 51.6 Ϯ 2.1 yr, body mass index: 24.5 Ϯ 1.1 kg/ms). None of them had a personal or family history of diabetes or obesity, nor were they receiving any medication. Subjects gave their written consent to the study after being informed of its nature, purpose, and potential risks. The protocol was approved by the ethical committee of the Centre Hospitalier Universitaire de Bordeaux (Bordeaux University Hospital).
Experimental protocol. All subjects were studied in the postabsorptive state after a 12-h overnight fast. To collect arterialized venous blood, a retrograde catheter was inserted in a dorsal hand vein, with the hand kept in a warming blanket. A forearm vein of the controlateral arm was catheterized for the infusions, and respiratory exchanges were measured with a Deltatrac metabolic monitor (Datex).
One hour after the beginning of respiratory gas exchange monitoring, a hyperinsulinemic hyperglycemic clamp was started, with con-comitant infusions of somatostatin (50 nmol ⅐ kg Ϫ1 ⅐ min Ϫ1 ), insulin (2.44 pmol ⅐ kg Ϫ1 ⅐ min Ϫ1 ), and glucagon (0.5 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) aimed at reproducing plasma insulin and glucagon concentrations usually observed 2 h after a 75-g oral glucose tolerance test (OGTT) (30) . These infusions were continuously administered during the next 420-min period, whereas plasma glucose levels were held constant at 6 or 10 mmol/l by means of a variable infusion of glucose (15 g/100 ml). A primed infusion of [ 2 H7]glucose (prime 12 mol/kg; Cambridge Isotope Laboratories, Andover, MA) was started at the same time. The infusion rate was proportional (0.6%) to the "cold" glucose infusion rate according to the hot-clamp technique (17) . An oral glucose load (700 mg/kg glucose, enriched with 5% D-[6,6-2 H2]glucose) was ingested at 240 min.
Blood samples were drawn at 0, 45, and 120 min and every 30 min thereafter for determination of plasma metabolites, hormones, and isotopic enrichments.
Analytical procedures. Plasma glucose was measured with a Hemocue glucose analyzer (Ä ngelholm, Sweden). Plasma insulin, C-peptide, and glucagon were measured using radioimmunoassays.
For isotopic analysis, plasma was deproteinized with 6% perchloric acid, neutralized with 3.2 M K 2CO3, and partially purified over sequential cation anion exchange resins (AG 50W-X8 and AG1X8; Bio-Rad, Richmond, CA). Pentacetyl glucose derivatives were analyzed by gas chromatography-mass spectrometry ( ]glucose isotopic enrichments expressed as molar ratios (tracer-to-tracee; MRD7) and plasma glucose concentrations (C) by the use of non-steady-state equations, with a pool fraction (p) of 0.75 and a distribution volume (V) of 0.2 l/kg (40):
By using D-[6,6-2 H2]glucose enrichments expressed as molar ratios MRD2, non-steady-state calculations were also performed for determination of rates of exogenous glucose appearance (R a E), as proposed by Proietto et al. (33) :
MRD2 of ingested glucose (4)
Total glucose output (TGO), representing the total flux through glucose-6-phosphatase, was calculated from RaT, RaE, and glucose infusion rate (M) before oral glucose ingestion
and after oral glucose ingestion
The same calculations were also performed using ([ 2 H7] ϩ [ 2 H6])-glucose isotopic enrichments to obtain net endogenous glucose production (EGP). The rate of glucose cycling (GC) was calculated as
To be detected as [ 2 H6]glucose, the infused [ 2 H7]glucose must 1) penetrate in glucose-producing cells and be phosphorylated by glucokinase, 2) release one deuterium in the reversible hexose-isomerase reaction, 3) be dephosphorylated by glucose-6-phosphatase, and 4) finally be released in the circulation. GC, therefore, represents the balance between the simultaneously occuring glucose phosphorylation catalyzed by glucokinase and dephosphorylation catalyzed by glucose-6-phosphatase.
Total glucose oxidation (GOx) and lipid oxidation rates were estimated from gaseous exchanges measurements, using the specific equation for GOx when negative lipid oxidation rates indicative of net lipogenesis from glucose were found (12) . Nonoxidative glucose disposal rates, representing the portion of plasma glucose stored as muscular and hepatic glycogen, and lipids, or recycled through the Cori cycle, were calculated (14) as
Statistical analysis. Results are shown as means Ϯ SE. The changes in hormones, substrate concentrations, and turnover rates over time, the comparisons between parameters measured with intravenous glucose alone (180 -240 min) and oral glucose (240 -480 min), and the results from tests at 6 and 10 mmol/l plasma glucose levels were analyzed by paired t-tests corrected for multiple comparisons. P Ͻ 0.05 was considered as significant.
RESULTS
Clamp conditions. In the postabsorptive state, plasma glucose and insulin levels did not differ before the 6 and 10 mmol/l tests. As shown on Fig. 1 , insulin levels were similarly increased during the 6 and 10 mmol/l tests, and a 4 mmol/l plasma glucose difference (P Ͻ 0.0001) was maintained throughout the clamp period. C-peptide levels were promptly suppressed after the onset of the somatostatin-insulin infusions and remained suppressed until the end of the tests. Glucagon levels were lower during the clamps than before, with no difference between the 6 and 10 mmol/l tests. Table 1 provides the hormonal levels at 0, 240 (before oral glucose ingestion), and 480 min (end of the tests). The glucose infusion rates before oral glucose ingestion were higher during the 10 mmol/l tests ( during the 6 and 10 mmol/l tests, with slightly lower levels during 10 mmol/l tests that required higher glucose infusion rates.
Rates of glucose disappearance. Before oral glucose ingestion, total R d T were slightly (ϩ14%), although not significantly, increased during the 10 mmol/l tests (Fig. 3) . This increase was amplified and became significant (ϩ28%, P Ͻ 0.05) after oral glucose ingestion. This was entirely due to an increased nonoxidative glucose disposal rate (10 vs. 6 mmol/l: ϩ20%, NS before oral glucose ingestion; ϩ40%, P Ͻ 0.05 after oral glucose ingestion), whereas glucose oxidation was similarly increased after oral glucose ingestion during the 6-(ϩ20%, P Ͻ 0.05) and 10 mmol/l tests (ϩ21%, P Ͻ 0.01). Lipid oxidation rates declined after oral glucose ingestion during both the 6 (Ϫ57%, P Ͻ 0.01) and 10 mmol/l (Ϫ24%, NS) tests. They did not differ between 6 and 10 mmol/l tests, and net de novo lipogenesis, as reflected by negative lipid oxidation rates, occured only marginally in two of the 6 mmol/l tests after oral glucose ingestion and one of the 10 mmol/l tests before oral glucose ingestion.
Rates of glucose appearance. R a E did not differ between the 6 and 10 mmol/l tests (Fig. 4) . They represented 55 and 63% of the 700 mg/kg oral glucose load, respectively. TGO also did not differ, although it tended to be lower before oral glucose ingestion during the 10 mmol/l tests. EGP was more inhibited during the 10 mmol/l tests (P Ͻ 0.05) before oral glucose ingestion but became similar in both tests after oral glucose ingestion. GC rates were higher throughout the 10 mmol/l tests (ϩ13% before oral glucose ingestion, P Ͻ 0.001; ϩ31% after oral glucose ingestion, P Ͻ 0.05). They were also higher after than they were before the oral glucose ingestion, both during the 6 (ϩ10%, P Ͻ 0.05) and 10 mmol/l (ϩ26%, P Ͻ 0.005) tests.
DISCUSSION
The major aim of this study was to find out whether and how hyperglycemia contributes to glucose tolerance in normal men. We examined the influence of a moderate and controlled hyperglycemia on glucose turnover rates both before and after oral glucose ingestion.
About 60% of the oral glucose load appeared in the systemic circulation during the 4 h after ingestion. This proportion is similar to those of a double-labeled OGTT study (25) or our previous double-labeled OG-clamp study (36) but lower than the 100% appearance of labeled glucose administered by duodenal infusions (16, 26) . The remaining 40% may be exogenous glucose metabolized in splanchnic tissues, which did not, therefore, reach the systemic circulation. Alternatively, it is possible that substantial portions of oral glucose remained unabsorbed in the intestinal lumen during the study period. substantially delays the rate of glucose absorption during constant duodenal glucose infusion and that about 36% of duodenally administered glucose remained in the intestinal lumen during the initial 3 h of infusion. Unfortunately, due to the known effect of somatostatin infusion, our present protocol cannot reliably assess first-pass splanchnic glucose uptake. Hyperglycemia alone, i.e., before glucose ingestion, increased glucose R d T , as reported during hyperglycemic clamps (1, 2, 5, 18, 28, 29, 43) . The increase of glucose R d T during 10 mmol/l tests did not reach significance, probably because of the moderate level of hyperglycemia chosen in these experiments. Glucose R d T further increased significantly after oral glucose ingestion. This was probably not a time effect because the tests conducted at 6 and 10 mmol/l had the same duration. The increase in glucose infusion rates during prolonged euglycemic clamps reached a plateau by 5-6 h (39), whereas the difference between 6 and 10 mmol/l tests was maintained during the 7th hour of our tests. It may reflect the synergistic effect of hyperglycemia and hyperinsulinemia on major glucose disposal pathways (13) . In contrast, a time effect could explain the slight increase in glucose oxidation that was observed after oral glucose ingestion: a ϩ10% increment has indeed been reported by Soop et al. (39) between the 4th and 7th hours of prolonged euglycemic clamps. Glucose oxidation did not differ between ]glucose (C). E, 6 mmol/l plasma glucose tests; F, 10 mmol/l plasma glucose tests. our 6 and 10 mmol/l tests; the higher glucose R d T during the 10 mmol/l tests were due to a significant increase of nonoxidative glucose disposal, which tended to rise further after oral glucose ingestion. Nonoxidative glucose disposal has been shown to plateau after the 6th hour of hyperinsulinemic euglycemic clamps (39) . Although hyperglycemia increases both glucose oxidative and nonoxidative disposal at basal insulin levels (44), the effect on nonoxidative glucose disposal is more pronounced during hyperinsulinemia (11, 28) . Our results do not differ from those of hyperglycemic clamp experiments on this point, but they extend these observations by showing that hyperglycemia induced by oral glucose further stimulates nonoxidative glucose disposal. Other investigators compared hepatic glucose storage (15) or direct vs. indirect hepatic glycogen synthesis (34) during intraduodenal (15) or oral vs. intravenous glucose administrations (34), but they failed to notice a specific effect of enteral glucose administration on hepatic glucose storage and glycogen synthesis. However, in these experiments, similar effects on hepatic and peripheral glucose handling were obtained at higher plasma glucose levels when glucose was administered intravenously. Our results show that such high levels of glycemia stimulate nonoxidative glucose disposal during oral glucose administration. This stimulation seems more effective after oral glucose ingestion, which accords with the hypothesis that a hepatic insulin sensitizing substance (32) may be secreted in that occurrence. The fate of the nonoxidized glucose could not be determined from our results. Similar (and marginally negative) rates of total lipid oxidation during the 6 and 10 mmol/l tests suggest that de novo lipogenesis can be neglected and that glycogen storage accounts for the major portion of nonoxidative glucose disposal. Lactate production and glucose lactate cycling may have been stimulated as well and may have contributed to maintain a significant glucose production after oral glucose.
EGP was more suppressed during the 10 mmol/l tests than it was during the 6 mmol/l tests before oral glucose ingestion, as reported in normal (4, 7) or type 1 diabetic subjects (23). We did not observe this suppressive effect of hyperglycemia after oral glucose ingestion; one-half of the suppression of EGP during OGTTs, therefore, seemed attributable to insulin. It is not clear why hyperglycemia did not further suppress it after oral glucose ingestion. Although systemic glycemia was maintained at 6 and 10 mmol/l throughout the tests, oral glucose administration would be expected to lead to a much larger increase in portal glycemia. Therefore, it is possible that the difference in systemic glycemia did not accurately reflect differences in portal glycemia during this part of the protocol. Alternatively, plasma glucagon concentrations are normally suppressed after oral glucose (30) , and the decline in glucagonemia contributes to inhibit glucose production (9) . This regulatory mechanism was disrupted in our experiments due to the infusion of somatostatin and maintenance of constant systemic and portal glucagon concentrations.
Net hepatic glucose output is determined by the balance of flux through glucokinase and glucose-6-phosphatase, the im- Fig. 3 . Rates of total glucose disappearance (Rd T) (mol ⅐ kg Ϫ1 ⅐ min Ϫ1 ) during the 6 and 10 mmol/l plasma glucose tests before (180 -240 min) and after (240 -480 min) oral glucose ingestion. White bars represent nonoxidative glucose disposal (GnonOx), and gray bars represent total glucose oxidation (GOx). *P Ͻ 0.05; **P Ͻ 0.01 between, before, and after oral glucose ingestion for the same plasma glucose level; §P Ͻ 0.05 between the 6 and 10 mmol/l plasma glucose tests at the same time. ) during the 6 and 10 mmol/l plasma glucose tests before (180 -240 min) and after (240 -480 min) oral glucose ingestion. White bars represent glucose cycling (GC), hatched bars represent endogenous glucose production (EGP), gray bars represent glucose infusion rates (M), and black bars represent rates of exogenous (oral) glucose appearance (Ra E). *P Ͻ 0.05; ***P Ͻ 0.001 between before and after oral glucose ingestion for the same plasma glucose level; §P Ͻ 0.05; § §P Ͻ 0.01; § § §P Ͻ 0.001 between 6 and 10 mmol/l plasma glucose tests at the same time.
portance of which is reflected in GC (10) . Hyperglycemia per se may inhibit net glucose output by increasing the flux via glucokinase (38) . For example, it has been shown that suppression of glucose production by hyperglycemia is blunted in maturity onset diabetes of the young patients with glucokinase mutations (42) . In addition, hyperglycemia has been reported to reduce the glucose-6-phosphatase activity, whereas the reduction of hepatic glucose production by insulin in euglycemic conditions is mediated by a decrease of intrahepatic glucose 6-phosphate concentrations (19, 38) . Our observation of a decreased net glucose production together with increased GC suggests that hyperglycemia increased the absolute fluxes through both glucokinase and glucose-6-phosphatase, but predominantly on glucokinase.
A GC rate increased by hyperglycemia during somatostatininsulin infusions has been reported in rats (20, 38) (4) . Methodological differences may account for this discrepancy. The monitoring of m ϩ 6 and m ϩ 7 during the infusion of only one isotope as permitted by the use of [ 2 H 7 ] glucose is probably more sensitive. In the experiments done by Bell et al., (4) the difference between the turnover rates tended to increase, although not significantly, with the plasma glucose levels (ϩ0.5, ϩ0.6, and ϩ0.8 mg⅐kg Ϫ1 ⅐min Ϫ1 at 95, 135, and 175 mg/dl, respectively). The slight hyperglycemia and lack of glucagon infusion may explain why the GC rate did not increase in the experiments done by Karlander et al. (24) ; glucagon is known to stimulate GC (31) . Similar isotope infusion rates during variable "cold" M, as employed in these previous studies, are also known to erroneously underestimate tracer-derived turnover rates, which may underestimate the difference between two calculated rates. In one study (42) ) and even higher with oral glucose ingestion (3.4 mol⅐kg Ϫ1 ⅐min Ϫ1 ). The difference between 2-3 Hand 3-3 H-derived turnover rates was also higher in the postprandial than in the postabsorptive state in normal subjects (3) .
In summary, we show that a moderately controlled hyperglycemia leads to an increased nonoxidative glucose disposal rate that contributes to glucose tolerance after oral glucose ingestion. EGP was not suppressed by moderate hyperglycemia after oral glucose ingestion, at least when glucagon levels were kept constant. Hyperglycemia and oral glucose ingestion increased the GC rate. The fate of the unoxidized glucose in hyperglycemia and its importance in pathological states of hyperglycemia, such as type 2 diabetes or impaired glucose tolerance, remain to be determined.
